RxDoctor Payments Data

Anthony Whitted

Cardiovascular Disease · Greenville, NCNPI 1902008600

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,662 of the $4,528 with a category attached, or 80.9%. 22 manufacturers reported payments, led by Johnson & Johnson at 28.4% of the total. Reporting peaked in 2019 at $2,366 and has fallen 82.8% since, to $407 in 2025.

$4,528in general payments, 2019–2025

Across 138 payments — averaging $32.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Angiodynamics, Inc.$986
  • E.r. Squibb & Sons, L.L.C.$634
  • Actelion Pharmaceuticals US, Inc.$202
  • Amgen$175
  • Novartis$170
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$84319%
  • Food & beverage$3,66281%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,528 in reported general payments places this provider in the 65th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina →

Other cardiovascular disease in Greenville

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →